Pharming Group N.V.
PHARNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $641.41M
- P/E (TTM)
- 69.45
- Forward P/E
- 145.69
- Dividend yield
- -
- 52-week range
- $9.32$21.34
- Volume (live)
- -
- Avg. volume (3M)
- 27.45K
Pharming Group (PHAR) Stock Price & Financial Analysis
Pharming Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $9.31 - $9.52 |
|---|---|
| 52-Week High | $21.34 |
| 52-Week Low | $9.32 |
| Open | $9.50 |
| Volume (last close) | 9.03K |
| Average Volume (3M) | 27.45K |
| Revenue (TTM) | 366.45M |
|---|---|
| Net Income (TTM) | 9.23M |
| Free Cash Flow (TTM) | 34.37M |
| EPS (TTM) | $0.13 |
| Profit Margin | 2.52% |
| Operating Margin | -17.31% |
| Return on Equity (ROE) | 3.41% |
| Debt to Equity | 0.36 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 641.41M |
|---|---|
| Shares Outstanding | 66.61M |
| P/E Ratio (TTM) | 69.45 |
| Forward P/E | 145.69 |
| Price to Sales (P/S) | 1.75 |
| Price to Book (P/B) | 2.37 |
| EV/EBITDA | 15.89 |
| 50-Day MA | $10.90 |
|---|---|
| 200-Day MA | $14.19 |
| 1-Year Change | −31.21% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Pharming Group at a Glance
As of the Oct 16, 2026 close, Pharming Group (PHAR) has a market capitalization of $641.41M. The stock trades at 69.5× trailing earnings, 145.7× forward earnings and 1.8× sales. Over the trailing twelve months it earned $9.23M on revenue of $366.45M (a 2.5% profit margin) and generated $34.37M of free cash flow. Revenue fell 99.6% year over year.
As of its latest reported balance sheet, it holds $158.28M in cash and securities against $97.87M of debt, a net cash position of $60.41M.
Pharming Group does not currently pay a dividend.
The share price is down 31.2% over the past year. At $9.36 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $9.32 to $21.34, below its 200-day moving average of $14.19.
Frequently Asked Questions About Pharming Group
What is the current stock price for PHAR?
As of the Oct 16, 2026 close, PHAR stock trades at $9.36. The 52-week range is $9.32–$21.34, with a day range of $9.31–$9.52.
What is the P/E ratio for PHAR?
As of the Oct 16, 2026 close, Pharming Group's trailing twelve-month (TTM) P/E ratio is 69.5, meaning investors pay $69.5 for every $1 of annual earnings. The forward P/E is 145.7, reflecting analyst expectations for future earnings. Pharming Group operates in the Healthcare sector.
Does PHAR pay dividends?
Pharming Group does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for PHAR?
Analyst ratings and recommendations for PHAR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PHAR?
As of the Oct 16, 2026 close, Pharming Group's market capitalization is $623.4M, classifying it as a small-cap company. Pharming Group operates in the Healthcare sector within the Biotechnology industry.